ETHK Labs Inc. (HKG:1931)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.940
0.00 (0.00%)
Apr 29, 2026, 4:08 PM HKT
-44.38%
Market Cap 1.51B
Revenue (ttm) 3.14B
Net Income (ttm) 38.87M
Shares Out 1.60B
EPS (ttm) 0.02
PE Ratio 39.18
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 524,000
Average Volume 1,014,320
Open 0.940
Previous Close 0.940
Day's Range 0.910 - 0.950
52-Week Range 0.910 - 12.860
Beta -0.34
RSI 30.69
Earnings Date Mar 27, 2026

About ETHK Labs

ETHK Labs Inc., an investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally. The company operates through three segments: Distribution Business, After-sales Services, and Self-branded Products Business. It offers IVD analysers, reagents, and other consumables for various IVD testing categories, including hematology and body fluid, immunoassay, clinical chemistry, immunology, microbiology, and point-of-care testing. The company also provides haemostasis products; solution services to the cl... [Read more]

Sector Healthcare
Founded 1993
Employees 877
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1931
Full Company Profile

Financial Performance

In 2025, ETHK Labs's revenue was 2.82 billion, a decrease of -10.81% compared to the previous year's 3.16 billion. Earnings were 34.93 million, a decrease of -86.59%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.